Nov 17, 2021 / 01:00PM GMT
Daniel Anthony Arias - Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
Okay. Welcome back, everyone. This is Day 3 of the Stifel Healthcare Conference, and we are on the life sciences and diagnostics track. And with us, to kick things off this morning, is Repligen. We have CEO, Tony Hunt; and CFO, Jon Snodgres, with us. Guys, thanks a bunch for joining us today and spending some time talking.
Anthony J. Hunt - Repligen Corporation - CEO, President & Director
Great. Good to be here, Dan.
Questions and Answers:
Daniel Anthony Arias - Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior AnalystYes. So Tony, we've taken a bit of a step backwards since June when we got together, and it felt like the virtual stuff was winding down, but we're -- it's okay. We're getting there. Hopefully, we get there soon anyway. And during that time, the business continues to perform well. 2021 is going to be another good year for you guys.
So can